BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15881478)

  • 1. Cost effectiveness of using carboxymethylcellulose dressing compared with gauze in the management of exuding venous leg ulcers in Germany and the USA.
    Guest JF; Ruiz FJ; Mihai A; Lehman A
    Curr Med Res Opin; 2005 Jan; 21(1):81-92. PubMed ID: 15881478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the cost implications of using carboxymethylcellulose dressing compared with gauze in the management of surgical wounds healing by secondary intention in the US and UK.
    Guest JF; Ruiz FJ
    Curr Med Res Opin; 2005 Feb; 21(2):281-90. PubMed ID: 15801999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cost-effectiveness of absorbent dressings in the treatment of highly exuding VLUs.
    Panca M; Cutting K; Guest JF
    J Wound Care; 2013 Mar; 22(3):109-10, 112-8. PubMed ID: 23665729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of the treatment of chronic wounds: hydroactive wound dressings in combination with enzymatic ointment versus gauze dressings in patients with pressure ulcer and venous leg ulcer in Germany.
    Bergemann R; Lauterbach KW; Vanscheidt W; Neander KD; Engst R
    Pharmacoeconomics; 1999 Oct; 16(4):367-77. PubMed ID: 10623365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Clinical and cost-effectiveness of absorbent dressings in the treatment of highly exuding VLUs'.
    Bishop S; Rolley J
    J Wound Care; 2013 Nov; 22(11):644, 646. PubMed ID: 24225605
    [No Abstract]   [Full Text] [Related]  

  • 6. A budget impact analysis comparing a Hydrofiber® ; dressing to an alginate dressing in managing exuding venous leg ulcers in France.
    Yan S; Colin X; Coudray-Omnès C; Guido-Morin P; Kommala DR
    Int Wound J; 2014 Jun; 11(3):304-13. PubMed ID: 23020759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of three adjunct cellular/tissue-derived products used in the management of chronic venous leg ulcers.
    Carter MJ; Waycaster C; Schaum K; Gilligan AM
    Value Health; 2014 Dec; 17(8):801-13. PubMed ID: 25498775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superabsorbent wound dressings versus foams dressings for the management of moderate-to-highly exuding venous leg ulcers in French settings: An early stage model-based economic evaluation.
    Veličković VM; Prieto PA; Krga M; Jorge AM
    J Tissue Viability; 2022 Aug; 31(3):523-530. PubMed ID: 35534319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of using a collagen-containing dressing plus compression therapy in non-healing venous leg ulcers.
    Guest JF; Rana K; Singh H; Vowden P
    J Wound Care; 2018 Feb; 27(2):68-78. PubMed ID: 29424641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compression for venous leg ulcers.
    O'Meara S; Cullum NA; Nelson EA
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000265. PubMed ID: 19160178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of a hydration response technology dressing in the treatment of venous leg ulcers in the UK.
    Walzer S; Dröschel D; Vollmer L; Atkin L; Ousey K
    J Wound Care; 2018 Mar; 27(3):166-172. PubMed ID: 29509113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness study of leg ulcer treatment in primary care. Comparison of saline-gauze and hydrocolloid treatment in a prospective, randomized study.
    Ohlsson P; Larsson K; Lindholm C; Möller M
    Scand J Prim Health Care; 1994 Dec; 12(4):295-9. PubMed ID: 7863149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers.
    Iglesias C; Nelson EA; Cullum NA; Torgerson DJ;
    Health Technol Assess; 2004 Jul; 8(29):iii, 1-105. PubMed ID: 15248939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers.
    Guest JF; Nagy E; Sladkevicius E; Vowden P; Price P
    J Wound Care; 2009 May; 18(5):216, 218-24. PubMed ID: 19440174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom.
    Ragnarson Tennvall G; Hjelmgren J
    Wound Repair Regen; 2005; 13(1):13-8. PubMed ID: 15659032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cadexomer iodine paste in the treatment of venous leg ulcers compared with hydrocolloid dressing and paraffin gauze dressing. Cadexomer Iodine Study Group.
    Hansson C
    Int J Dermatol; 1998 May; 37(5):390-6. PubMed ID: 9620490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia.
    Cheng Q; Gibb M; Graves N; Finlayson K; Pacella RE
    BMC Health Serv Res; 2018 Jun; 18(1):421. PubMed ID: 29880046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply: To PMID 23665729.
    Panca M; Cutting KF; Guest JF
    J Wound Care; 2013 Nov; 22(11):646-8. PubMed ID: 24288785
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effective use of silver dressings for the treatment of hard-to-heal chronic venous leg ulcers.
    Jemec GB; Kerihuel JC; Ousey K; Lauemøller SL; Leaper DJ
    PLoS One; 2014; 9(6):e100582. PubMed ID: 24945381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of treating vascular leg ulcers with UrgoStart(®) and UrgoCell(®) Contact.
    Augustin M; Herberger K; Kroeger K; Muenter KC; Goepel L; Rychlik R
    Int Wound J; 2016 Feb; 13(1):82-7. PubMed ID: 24618370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.